In 2026, adults with acne who can become pregnant still need two in-clinic pregnancy tests before starting isotretinoin. Later refills may allow clinician-approved home testing after August 2026, but the first prescription keeps a strict 7-day pickup window. iPLEDGE is the FDA safety program for isotretinoin that prevents pregnancy during treatment.
The FDA approved the modifications on Feb. 9, 2026, with changes taking effect 180 days later on Aug. 9, 2026, according to the FDA approval notice. For adults weighing isotretinoin for persistent acne, that schedule sets what to book and when to pick up.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does pretreatment testing still require?
- How does the 7-day prescription window work?
- What if you miss the pickup window?
- What eases after you start?
What does pretreatment testing still require?
Pretreatment testing must occur in a medical setting. That means a prescriber office, clinic, or laboratory, as explained by the National Community Pharmacists Association in its summary of the FDA changes. FDA labeling calls for two negative urine or serum tests with sensitivity of at least 25 mIU/mL, taken at least 19 days apart, with CLIA-certified lab confirmation.
Patients also complete 30 days of contraception or abstinence before starting, as outlined in FDA counseling materials. A practical sequence looks like this. Use it to avoid timing gaps:.
- Book test 1 in clinic and start pregnancy prevention the same week.
- Book test 2 at least 19 days later in clinic.
- Ask where results go and who confirms them for iPLEDGE.
How does the 7-day prescription window work?
The prescription window is short. The FDA states in the iPLEDGE REMS guide that prescriptions for patients who can become pregnant allow no more than a 30-day supply.
The fill and pickup must occur within 7 days, counting the test specimen date as Day 1. That leaves little slack for lab delays or pharmacy stock. Ask your clinic which date counts and set a pickup reminder for Day 2 or 3.
What if you miss the pickup window?
The Journal of Dermatology Nurses' Association reports in its iPLEDGE update report that FDA eliminated the 19-day lockout after a missed 7-day window. A repeat pregnancy test can now be done immediately without an added waiting period.
You still need a new negative test and a new 7-day count. Call the clinic right away, retest, and confirm pharmacy hours before the prescription is re-entered.
What eases after you start?
Dermatology Times reports prescribers may allow home or outside-setting tests during and after treatment with clinician approval. Approval is case by case, so do not switch settings without clear clinician direction. Medaptly summarizes that monthly counseling documentation is no longer required for patients who cannot become pregnant.
Isotretinoin remains FDA-indicated only for severe recalcitrant nodular acne in qualifying patients age 12 and older, per the FDA prescriber guide. Confirm with your prescriber whether home testing fits your case and where follow-up specimens go. Plan two in-clinic visits first, then ask about home-test approval for refills after August 2026.
You Might Also Like
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Access and Prescription-Window Questions for Adult Acne Patients
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: A Verification Checklist for Adult Acne Patients
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: A Verification Checklist for Adult Acne Patients